Redeye Members Network

To access members-only content, you must login or register an account. The Redeye membership is free, but you need to apply via our application form.

Our membership is about gaining access to unique research and knowledge through our analysts and a network of peers. Be the first to get information about news and research in the Nordic life science and technology sectors and use our tools and education to reach your personal and professional goals in investing.

NEXT GENERATION INVESTMENT BANKING

  • Peers

Catalyst Potential

It is important to look beyond the numbers and seek a likely catalysts, which could unlock value, and estimate how long it will take for the catalyst to play out. These events, or Catalyst Potential, reduce risk by narrowing the gap between price and value in a more predictable way. This is particularly important when investing in a low-quality business where time is like a ticking bomb stacked against the company.

Catalyst Potential is a Premium members feature in Redeye Universe.

APPLY FOR MEMBERSHIP

TODAY

Day High
30.90
30.10
0.40
-1.3%
Day Low
29.90
Day Open
30.00
Prev Close
30.10
VWAP
30.2
Volume
156K
Turnover
4.704M
Top Broker
VWAP
31.0
Avg Volume
256K
Avg Turnover
7.945M
Top Brokers
AVA/NON

52 WEEK SUMMARY

Price Range
Beta
n/a
Market Cap
2,473.2M
Total Return
12.0%
Trailing P/E
N/A
Div Yield
N/A%
Shares Outstanding
82.2M
Next Earnings Date
10 May
Stock Exchange
NASDAQ Stockholm

Identify and measure trend strength in stocks with our Momentum tool to identify potential entry and exit signals. The tool provides a set of the most simple but powerful indicators that identify whether a stock is under sell or buy pressure.

Relative Price Strength
Rel Price Chg 3 Months 10.5%
Rel Price Chg 12 Months -4.6%
Volume Trend
Avg Vol 10 vs 60 Days -45.6%
Price vs...
52-Week High -27.2%
50-Day Moving Average 4.6%
200-Day Moving Average 0.6%

Historic pricing of Karo Pharma

Last price: 30.10 SEK

Loading data...

Prev Close [[ prevClose|number:2 ]] SEK Change [[ changeValue|number:2 ]] %
High [[ highValue|number:2 ]] SEK Avg Daily Volume [[ avgVolume|number:0 ]] Shares
Low [[ lowValue|number:2 ]] SEK Avg Daily Turnover [[ graphAvgTurnover|number:2 ]] SEK

Management

Maria Sjöberg, CEO

Executive Board

Anders Lönner, Chairman of the board

Major Holders

Owner Equity Votes
Försäkringsaktiebolaget, Avanza Pension 8.9%
8.9%
Anders Lönner 5.6%
5.6%
JP Morgan Bank 4.4%
4.4%
Nordnet Pensionsförsäkring AB 3.4%
3.4%
Nomic AB 2.6%
2.6%

Insider transaction summary

Total insider purchases and sales reported

Timeframe Transactions Net Shares
Last 12 Weeks

0 Purchases

+ 0

0 Sales

- 0

Last 24 Weeks

0 Purchases

+ 0

0 Sales

- 0

Most recent insider transactions

Exclusive for members
Report Date Name Position Transaction Shares Chg Est Value (SEK)
2015-12-15 Kvist, Malin ANB Sale + 23 199
2015-12-15 Svensson, Malin ANB Sale + 29 29
2015-12-15 Svensson, Sture ANB Sale + 32 152
2015-12-15 Svensson, Malin ANB Sale + 59 148
2015-12-15 Kvist, Sture ANB Sale + 29 7

Source: Millistream – FI

More
  • Profitability
  • ROE
  • ROCE
  • ROIC
  • EBITDA margin
  • EBIT margin
  • Net margin
  • Per share data (SEK)
  • EPS
  • EPS adj
  • Dividend
  • Net debt
  • Total shares
  • Valuation
  • EV (SEKm)
  • P/E
  • P/E diluted
  • P/Sales
  • EV/Sales
  • EV/EBITDA
  • EV/EBIT
  • P/BV
  • Capital structure
  • Equity ratio
  • Debt/equity ratio
  • Net debt (SEKm)
  • Capital employed (SEKm)
  • Capital turnover rate
Previous year Next year
Previous year Next year
    (SEKm)
  • Net sales
  • Total operating costs
  • EBITDA
  • Depreciation
  • Amortization
  • Impairment charges
  • EBIT
  • Share in profits
  • Net financial items
  • Exchange rate dif.
  • Pre-tax profit
  • Tax
  • Net earnings
Previous year Next year
Previous year Next year
    (SEKm)
  • Assets
  • Current assets
  • Cash in banks
  • Receivables
  • Inventories
  • Other current assets
  • Current assets
  • Fixed assets
  • Tangible assets
  • Associated comp.
  • Investments
  • Goodwill
  • Cap. exp. for dev.
  • O intangible rights
  • O non-current assets
  • Total fixed assets
  • Deferred tax assets
  • Total (assets)
  • Liabilities
  • Current liabilities
  • Short-term debt
  • Accounts payable
  • O current liabilities
  • Current liabilities
  • Long-term debt
  • O long-term liabilities
  • Convertibles
  • Total Liabilities
  • Deferred tax liab
  • Provisions
  • Shareholders' equity
  • Minority interest (BS)
  • Minority & equity
  • Total liab & SE
Previous year Next year
Previous year Next year
    (SEKm)
  • Net sales
  • Total operating costs
  • Depreciations total
  • EBIT
  • Taxes on EBIT
  • NOPLAT
  • Depreciation
  • Gross cash flow
  • Change in WC
  • Gross CAPEX
  • Free cash flow
Previous year Next year
Previous year Next year
More